Watch this on-demand panel, moderated by Formlabs, to hear perspectives from a health system, two commercial medical device firms, and the FDA on the current state of 3D printing in the medical industry. They will go over how they view the role of additive in the future of healthcare and how they can collaborate more effectively in this area to improve clinical, financial, and operational challenges for healthcare systems.
The representatives from the FDA, industry, and healthcare discuss recent developments and address some intriguing questions:
- Will health systems that leverage in-house 3D printing become less reliant on medical device manufacturers to address their needs?
- In the current healthcare landscape, how might 3D printing support strategic priorities for hospitals and medtech companies?
- What benefits does the technology offer to commercial medtech firms, and how do those get passed along to providers and/or patients?
- How might an evolving regulatory environment affect the adoption and use of this technology by providers and device manufacturers?
